We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+9.66%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$9.13B
AUM Growth
+$334M
Cap. Flow
-$281M
Cap. Flow %
-3.08%
Top 10 Hldgs %
21.52%
Holding
2,368
New
73
Increased
154
Reduced
1,152
Closed
75

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$34.6M
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$3.94M
3
CZR icon
Caesars Entertainment
CZR
+$3.71M
4
IAA
IAA, Inc. Common Stock
IAA
+$3.57M
5
RUN icon
Sunrun
RUN
+$3.42M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$22.2M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$15.9M
3
MSFT icon
Microsoft
MSFT
+$13.6M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$9.6M
5
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$9.15M

Sector Composition

Rank Sector Weight
1 Technology 22.17%
2 Healthcare 13.84%
3 Financials 12.41%
4 Consumer Discretionary 11.36%
5 Industrials 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KRA
1726
DELISTED
Kraton Corporation
KRA
$250K ﹤0.01%
14,021
– –
KRRO icon
1727
Korro Bio
KRRO
$196M
$250K ﹤0.01%
260
– –
LMAT icon
1728
LeMaitre Vascular
LMAT
$1.88B
$249K ﹤0.01%
7,651
– –
KREF
1729
KKR Real Estate Finance Trust
KREF
$500M
$248K ﹤0.01%
15,022
– –
PFC
1730
DELISTED
Premier Financial Corp. Common Stock
PFC
$248K ﹤0.01%
15,929
– –
BDTX icon
1731
Black Diamond Therapeutics
BDTX
$117M
$246K ﹤0.01%
8,148
+1,831
+29% +$55.7K
IGMS
1732
DELISTED
IGM Biosciences
IGMS
$246K ﹤0.01%
3,333
– –
AHCO icon
1733
AdaptHealth
AHCO
$767M
$245K ﹤0.01%
+11,254
New +$236K
PRPL icon
1734
Purple Innovation
PRPL
$28.8M
$245K ﹤0.01%
395
+108
+38% +$57.4K
APOG icon
1735
Apogee Enterprises
APOG
$888M
$245K ﹤0.01%
11,475
– –
NVEE
1736
DELISTED
NV5 Global
NVEE
$245K ﹤0.01%
18,544
– –
INGN icon
1737
Inogen
INGN
$155M
$244K ﹤0.01%
8,423
– –
EVER icon
1738
EverQuote
EVER
$877M
$244K ﹤0.01%
6,305
– –
HA
1739
DELISTED
Hawaiian Holdings, Inc.
HA
$244K ﹤0.01%
18,895
– –
TRTX
1740
TPG RE Finance Trust
TRTX
$617M
$243K ﹤0.01%
28,755
– –
MGPI icon
1741
MGP Ingredients
MGPI
$392M
$243K ﹤0.01%
6,119
– –
LL
1742
DELISTED
LL Flooring Holdings, Inc.
LL
$243K ﹤0.01%
11,017
-3,827
-26% -$81.7K
PDFS icon
1743
PDF Solutions
PDFS
$2.12B
$243K ﹤0.01%
12,971
– –
KRYS icon
1744
Krystal Biotech
KRYS
$9.74B
$243K ﹤0.01%
5,633
– –
CIR
1745
DELISTED
CIRCOR International, Inc
CIR
$242K ﹤0.01%
8,858
– –
SPNT icon
1746
SiriusPoint
SPNT
$2.7B
$242K ﹤0.01%
34,789
– –
ARQT icon
1747
Arcutis Biotherapeutics
ARQT
$3.25B
$242K ﹤0.01%
8,244
+2,902
+54% +$77.5K
SCSC icon
1748
Scansource
SCSC
$1.06B
$241K ﹤0.01%
12,162
– –
HSTM icon
1749
HealthStream
HSTM
$849M
$241K ﹤0.01%
12,016
– –
EBSB
1750
DELISTED
Meridian Bancorp, Inc.
EBSB
$241K ﹤0.01%
23,292
– –
68 69
70
71 72

Similar funds

Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
NAM
Nissay Asset Management Tokyo, Japan $18.9B AUM 27.21% 1-Year Est. Return

MetLife Investment Management's Q3 2020 Portfolio in Review

As of Q3 2020, MetLife Investment Management held 2,368 positions worth $9.13B, up 3.8% from $8.79B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

MetLife Investment Management withdrew a net $281M in Q3 2020, closing 75 positions and reducing 1,152 holdings. Its most notable exit was Slack Technologies, Inc., an estimated $7.44M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, MetLife Investment Management opened a new position in Jazz Pharmaceuticals worth $4.53M.

  • MetLife Investment Management's largest Q3 2020 buy was Jazz Pharmaceuticals: 31,753 shares worth $4.53M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $34.6M increase.
  • MetLife Investment Management's biggest Q3 2020 reduction was Apple, cutting an estimated $22.2M.
  • MetLife Investment Management fully exited Slack Technologies, Inc. in Q3 2020, selling an estimated $7.44M.
  • MetLife Investment Management's ten largest holdings make up 22% of its $9.13B portfolio in Q3 2020.
  • MetLife Investment Management opened 73 new positions and closed 75 in Q3 2020.
  • MetLife Investment Management's portfolio value rose 3.8% quarter-over-quarter to $9.13B.

Based on MetLife Investment Management's 13F filing for Q3 2020, filed 13 Nov 2020.